Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital

被引:4
|
作者
Clapham, Rachel E. [1 ]
Speed, Victoria [1 ,2 ]
Czuprynska, Julia [1 ]
Gazes, Anna [1 ]
Guppy, Simon [1 ]
Patel, Raj K. [1 ]
Rea, Catherine [1 ]
Vadher, Bipin [1 ]
Arya, Roopen [1 ]
Roberts, Lara N. [1 ]
机构
[1] Kings Coll Hosp NHS Fdn Trust, Kings Thrombosis Ctr, Dept Haematol Med, London, England
[2] Kings Coll London, Inst Phar maceut Sci, London, England
关键词
rivaroxaban; superficial vein thrombosis; anticoagulants; factor Xa inhibitor; DIAGNOSIS;
D O I
10.1111/bjh.17757
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E3 / E6
页数:4
相关论文
共 50 条
  • [31] Management of postpartum ovarian vein thrombosis. The experience of Amiens university hospital
    Lerouge, J.
    Sanguin, S.
    Gondry, J.
    Sergent, F.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2016, 44 (02): : 88 - 95
  • [32] The management of mesenteric vein thrombosis: a single institution's experience
    Yanar, Fatih
    Agcaoglu, Orhan
    Gok, All Fuat Kaan
    Sarici, Inanc Samil
    Ozcinar, Beyza
    Aksakal, Nihat
    Aksoy, Murat
    Ozkurt, Enver
    Kurtoglu, Mehmet
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2013, 19 (03): : 223 - 228
  • [33] Single centre experience of the management of superficial vein thrombosis with prophylactic low-molecular-weight heparin
    Gouveia, Sofia
    Roberts, Lara N.
    Czuprynska, Julia
    Patel, Raj K.
    Arya, Roopen
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) : 682 - 684
  • [34] Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin
    Karathanos, Christos
    Kakkos, Stavros K.
    Georgiadis, Georgios
    Ioannou, Christos
    Vasdekis, Spyros
    Chatzis, Dimitrios
    Latzios, Panagiotis
    Giannoukas, Athanasios D.
    PHLEBOLOGY, 2023, 38 (03) : 141 - 149
  • [35] Recent findings in the epidemiology, diagnosis and treatment of lower-limb superficial-vein thrombosis
    Decousus, H.
    Accassat, S.
    El Jaouhari, A.
    Frappe, P.
    Bertoletti, L.
    REVUE DE MEDECINE INTERNE, 2012, 33 : S33 - S34
  • [36] Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: The first case-control blinded study
    Khorvash, Fariborz
    Farajpour-Khanaposhtani, Mohammad Javad
    Hemasian, Helia
    Saadatnia, Sayed Mohammad
    CURRENT JOURNAL OF NEUROLOGY, 2021, 20 (03):
  • [37] Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism
    Burness, Celeste B.
    Perry, Caroline M.
    DRUGS, 2014, 74 (02) : 243 - 262
  • [38] The treatment effect of rivaroxaban on clot characteristics in patients who present acutely with first time deep vein thrombosis
    Evans, V. J.
    Lawrence, M.
    Whitley, J.
    Johns, C.
    Pillai, S.
    Hawkins, K.
    Power, K.
    Morris, K.
    Williams, P. R.
    Evans, P. A.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2022, 80 (02) : 139 - 151
  • [39] Anticoagulants for the treatment of isolated lower limb superficial vein thrombosis a Bayesian network meta-analysis of randomized controlled trials
    Bontinis, Alkis
    Pouliopoulou, Ioanna
    Bontinis, Vangelis
    Liakopoulos, Vassilios
    Giannopoulos, Argirios
    Chatzimpalasi, Theodora
    Ktenidis, Kiriakos
    THROMBOSIS RESEARCH, 2024, 241
  • [40] Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism
    van Bellen, Bonno
    Bamber, Luke
    de Carvalho, Francine Correa
    Prins, Martin
    Wang, Maria
    Lensing, Anthonie W. A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 829 - 837